Bruce M Halpryn
Algemeen Directeur bij Eikonoklastes Therapeutics, Inc.
Actieve functies van Bruce M Halpryn
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Eikonoklastes Therapeutics, Inc.
 Eikonoklastes Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Eikonoklastes Therapeutics, Inc. provides pharmaceutical services. It develops a state of the art immune conjugate technology targeting tissue factor for the treatment of solid tumors and other pathologic conditions. The company was founded by Zhiwei Hu and is headquartered in Cincinnati, OH. | Algemeen Directeur | 01-03-2019 | - |
| Voorzitter | 01-03-2019 | - | |
| Oprichter | 01-03-2019 | - |
Loopbaan van Bruce M Halpryn
Eerdere bekende functies van Bruce M Halpryn
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Myonexus Therapeutics, Inc.
 Myonexus Therapeutics, Inc. BiotechnologyHealth Technology Myonexus Therapeutics, Inc. operates as a clinical stage company. It engages in the research and development of limb-girdle muscular dystrophy gene treatments. The company was founded by Michael Triplett and Bruce Halpryn in February 2017 and is headquartered in New Albany, OH. | Directeur/Bestuurslid | 01-02-2017 | 01-04-2024 |
| Operationeel Directeur | 01-02-2017 | 01-04-2024 | |
| Oprichter | 01-02-2017 | 01-04-2024 | |
| Bedrijfssecretaris | 01-02-2017 | 01-04-2024 |
Statistieken
Internationaal
| Verenigde Staten | 3 |
Operationeel
| Founder | 2 |
| Director/Board Member | 1 |
| Chief Operating Officer | 1 |
Sectoraal
| Health Technology | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Myonexus Therapeutics, Inc.
Myonexus Therapeutics, Inc. BiotechnologyHealth Technology Myonexus Therapeutics, Inc. operates as a clinical stage company. It engages in the research and development of limb-girdle muscular dystrophy gene treatments. The company was founded by Michael Triplett and Bruce Halpryn in February 2017 and is headquartered in New Albany, OH. | Health Technology |
Eikonoklastes Therapeutics, Inc.
Eikonoklastes Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Eikonoklastes Therapeutics, Inc. provides pharmaceutical services. It develops a state of the art immune conjugate technology targeting tissue factor for the treatment of solid tumors and other pathologic conditions. The company was founded by Zhiwei Hu and is headquartered in Cincinnati, OH. | Health Technology |
- Beurs
- Insiders
- Bruce M Halpryn
- Ervaring
